Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Tvardi Therapeutics (TVRD) Return on Sales (2016 - 2025)

Tvardi Therapeutics' Return on Sales history spans 13 years, with the latest figure at 0.01% for Q1 2025.

  • On a quarterly basis, Return on Sales rose 13.0% to 0.01% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.03%, a 4.0% increase, with the full-year FY2024 number at 0.1%, down 4.0% from a year prior.
  • Return on Sales hit 0.01% in Q1 2025 for Tvardi Therapeutics, up from 0.07% in the prior quarter.
  • Over the last five years, Return on Sales for TVRD hit a ceiling of 0.0% in Q2 2021 and a floor of 0.41% in Q4 2021.
  • Historically, Return on Sales has averaged 0.08% across 5 years, with a median of 0.06% in 2022.
  • Biggest five-year swings in Return on Sales: crashed -41bps in 2021 and later skyrocketed 31bps in 2022.
  • Tracing TVRD's Return on Sales over 5 years: stood at 0.41% in 2021, then skyrocketed by 76bps to 0.1% in 2022, then fell by -13bps to 0.11% in 2023, then surged by 32bps to 0.07% in 2024, then skyrocketed by 87bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for TVRD at 0.01% in Q1 2025, 0.07% in Q4 2024, and 0.02% in Q3 2024.